Form 4 for KURA Kura Oncology, Inc.
Accepted 2023-01-31 00:00:00 ET · period of report 2023-01-27 · accession 0001209191-23-005748 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-31 | 2023-01-27 | KURA | FLOWERS KIRSTEN | CCO, Chief Strategy Off | S - Sale | $13.89 | -1,906 | 20.6K | -8% | -$26.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-27 | S | D | 1,906 | $13.89 | 20,605 | D | — | — | (F1) Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22. |